IJE Advance Access published online on July 17, 2006
International Journal of Epidemiology, doi:10.1093/ije/dyl156
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Service des maladies infectieuses et tropicales CHU de Treichville, Abidjan, Côte d'Ivoire
* To whom correspondence should be addressed.
Commentary
Commentary: Decline of HIV-2 prevalence in West Africa: good news or bad news?
Serge Eholié 1 and Xavier Anglaret 2 *
2 INSERM U593, Université Bordeaux 2, Bordeaux, France
Xavier Anglaret, E-mail: Xavier.Anglaret{at}isped.u-bordeaux2.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Int. J. Epidemiol.:
- Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2
- Maarten F. Schim van der Loeff, Akum Aveika Awasana, Ramu Sarge-Njie, Marianne van der Sande, Assan Jaye, Saihou Sabally, Tumani Corrah, Samuel J. McConkey, and Hilton C. Whittle
Int. J. Epidemiol. 2006 10.1093/ije/dyl037.[Abstract]
This article has been cited by other articles:
![]() |
M. L. Ntemgwa, T. d. Toni, B. G. Brenner, R. J. Camacho, and M. A. Wainberg Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2 Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3611 - 3619. [Full Text] [PDF] |
||||
